Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins
Authors:
- 7 December 2004
- journal article
- Published by Wiley in Journal of Pineal Research
- Vol. 38 (4) , 231-239
Abstract
Abstract: Melatonin has been shown to bind to the MT1 G protein‐coupled receptor (GPCR) in MCF‐7 breast cancer cells to modulate the estrogen response pathway suppressing estrogen‐induced estrogen receptor alpha (ERα) transcriptional activity, blunting ER/DNA binding activity and suppressing cell proliferation. In these studies we have examined the effect of melatonin on the transcriptional activity of the ERα and other members of the steroid/thyroid hormone receptor superfamily, namely, the glucocorticoid receptor (GR) and the retinoic acid receptor alpha (RARα). As with the ERα, melatonin represses ligand (dexamethasone)‐induced activation of the GR. This effect of melatonin on ERα and GR is blocked by pertussis toxin (PTX) suggesting that melatonin's actions may be mediated via a PTX‐sensitive Gαi protein. In contrast, melatonin potentiates the action of all‐trans‐retinoic acid on RARα transcriptional activation and enhances RARα/DNA binding activity, an action which is not PTX‐sensitive. Expression of a dominant‐positive Gαi2 protein, with which the MT1 receptor has been shown to couple, is able to mimic the effect of melatonin on ERα but not RARα transcriptional activation in breast cancer cells. This demonstrates that GPCRs can modulate the transcriptional activity of various steroid receptors in response to their ligand through activation of different G protein signaling pathways.Keywords
This publication has 39 references indexed in Scilit:
- Melatonin, an Endogenous-specific Inhibitor of Estrogen Receptor α via CalmodulinJournal of Biological Chemistry, 2004
- Molecular and pharmacological evidence for MT 1 melatonin receptor subtype in the tail artery of juvenile Wistar ratsBritish Journal of Pharmacology, 1999
- Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factorsMolecular and Cellular Endocrinology, 1998
- The Mel1a melatonin receptor gene is expressed in human suprachiasmatic nucleiNeuroReport, 1996
- Suppressive effect by melatonin on different phases of 9,10-dimethyl-1,2-benzanthracene (DMBA)-induced rat mammary gland carcinogenesisAnti-Cancer Drugs, 1991
- Effects of melatonin on the cell cycle kinetics and “estrogen‐rescue” of MCF‐7 human breast cancer cells in cultureJournal of Pineal Research, 1991
- Both Pertussis Toxin‐Sensitive and Insensitive G‐Proteins Link Melatonin Receptor to Inhibition of Adenylate Cyclase in the Ovine Pars TuberalisJournal of Neuroendocrinology, 1990
- Effects of the pineal hormone melatonin on the anchorage-independent growth of human breast cancer cells (MCF-7) in a clonogenic culture systemCancer Letters, 1990
- Studies on the effects of the pineal hormone melatonin on an androgen-insensitive rat prostatic adenocarcinoma, the Dunning R 3327 HIF tumorJournal of Neural Transmission, 1988
- Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracene-(DMBA)-induced mammary tumorigenesisJournal of Neural Transmission, 1986